ISTP, 8025 Lamon Ave. Skokie, Il 60077

ISTP Campus Improvements

The transformation of the ISTP campus draws inspiration from the fusion of science and nature, reinforcing the campus’s commitment to wellness and sustainability. Updated common areas are designed to promote physical activity, social interaction, collaboration and a sense of connection in a dynamic scientific setting, marking a new chapter in the campus’s evolution.

The dramatic four-story atrium at the heart of the campus is anchored by a vertical volume of stacked meeting spaces clad in wood slats. Thoughtful lighting upgrades help define the architectural volume, while moveable furniture allows the large space to seamlessly transition from a third workplace to hosting informal gatherings and community events.

Hospitality-inspired areas for relaxation provide a comforting escape from structured lab environments. The redesign also extends to the auditorium and conference center, equipped with new technology, while refreshed locker rooms and restrooms feature spa-like amenities to further enrich the user experience.

Sustainability is a key focus of the design, with recycled content and carbon-neutral products prioritized in material selection. Biophilia-themed furnishings and finishes, along with carefully selected art pieces throughout the campus support the concept of scientific journey.

To learn more about ISTP leasing options, click here. 

Comments Off on ISTP Campus Improvements Blog, News

Read more

Trends to Watch in 2024

6 Life Science Trends to Watch in 2024.

The life sciences industry is undergoing significant disruptions, fueled by technological advancements such as additive manufacturing, 3D printing, closed-loop continuous systems and AI. New scientific discoveries, supply-demand dynamics, sustainable innovations and strategic partnerships are creating numerous opportunities for life sciences companies, investors and developers.

This perfect storm of activity has the potential to revolutionize the utilization of real estate in the long run.  Explore six trends poised to impact the life sciences industry in the year ahead.

What will matter most?

  • Everything is hyperlocal.
  • It’s an occupier’s market.
  • Doing more with less
  • Sustainable design and operations
  • Wave of new modalities.
  • Patent cliff is the perfect storm for M&A

These trends have a unique and long-term impact on your locations, workplace environments and overall portfolio.

Click here for more information from JLL.

Comments Off on Trends to Watch in 2024 Blog

Read more

Cour: New COO

COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system, announced the appointment of Dannielle Appelhans as Chief Operating Officer. In this role, Ms. Appelhans will oversee and execute the Company’s research and development, technical development, technical operations, and quality as well as be a significant contributor to corporate strategy and other business operations.

Ms. Appelhans served most recently as the Chief Executive Officer of Rubius Therapeutics, Inc., a publicly traded and clinical-phase biopharmaceutical company pioneering cellular medicines. She previously served as its Chief Operating Officer, where she oversaw corporate strategy, communications, quality, technical development, and operations.

Prior to joining Rubius, she worked at Novartis and held roles of increasing responsibility in operations and strategy culminating in her serving as Senior Vice President of Technical Operations and Chief Technical Officer at Novartis Gene Therapies, where she oversaw late-stage clinical development and commercial manufacturing.

Said John J. Puisis of COUR, “Dannielle’s operating experience will be pivotal in accelerating COUR’s therapeutic programs and positioning COUR in becoming a world class leader in antigen-specific immune tolerance.”

Click for the complete announcement.

Comments Off on Cour: New COO Blog, News

Read more

Health Care & Life Sciences

Chicago Health Care and Life Sciences Real Estate Conference @ISTP.

Chicagoland is a leader in healthcare and an emerging life sciences hub. Attendees gained exclusive insights into the latest trends and actionable strategies to incorporate old and new techniques to improve the overall patient experience.

The program covered the future of Chicago’s life sciences sector as thought leaders discussed where the future of the asset class is headed. What does the market need for continued growth and expansion and what challenges are being faced? Industry leaders discussed how owners and developers are capitalizing on the healthcare and life sciences industries.

Topics included:

CHICAGOLAND’S EMERGENCE AS A LIFE SCIENCES HUB – How the City is Positioning Itself to Attract Highly Sought-After Investment and Best-in-Class Innovation

HEALTHCARE REPORT – Dissecting Chicagoland’s Development Pipeline, Tech and Operations, the Latest Innovations, and More!

STRATEGIC LAB DESIGN & CONSTRUCTION
Best Practices for New-Build Facilities and Adaptive Reuse Lab Space

For more pictures of this event, click here. 

For a complete program outline, click here.

 

Comments Off on Health Care & Life Sciences Blog, Events

Read more

LanzaTech Goes Public

Skokie-based LanzaTech, is a biotech company that works to recycle carbon waste into everyday products and materials like fuels, fabrics and packaging. LanzaTech announced its plans to enter the public market through a merger with special purpose acquisition company AMCI Acquisition Corp. II. The deal will make it the first carbon capture and transformation business in the public space, according to the company.

When the acquisition closes, the combined company is expected to trade under the Nasdaq ticker symbol “LNZA.” The transaction will raise about $275 million in proceeds, money LanzaTech plans to put toward executing its business plan, accelerating commercial operations, funding partner development projects and building out its tech. The deal is set to close in the third quarter of 2022.

“LanzaTech revolutionary technology repurposes waste carbon for use as a feedstock to make the products we use in our daily lives—from yoga pants to jet fuel,” said Dr. Jennifer Holmgren, LanzaTech’s CEO. “Our carbon recycling technology is like retrofitting a brewery onto an emission source like a steel mill or a landfill site, but instead of using sugars and yeast to make beer, pollution is converted by bacteria to fuels and chemicals.”

“We are showing the world what is possible when we radically rethink how we source, use and dispose of carbon. We are excited to be on this journey,” Holmgren further noted.

For more details, click here.

Comments Off on LanzaTech Goes Public Blog, Events

Read more

Cour Pharma Expands at ISTP

To meet the increasing demand for medical research space in the Chicagoland area, Cour Pharmaceuticals’ life science and emerging biotechnology footprint is expanding within the Illinois Science and Technology Park in Skokie, Ill. With the addition, Cour Pharmaceuticals now leases around 25,000 sq. ft. in the park.

COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. COUR’s platform of immune-modifying nanoparticles treats the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression.

“Continued rapid growth for high-potential life science startups are emerging in Chicago and in addition to talent, life sciences companies like COUR will continue to need access to more specialized wet and dry lab space along with capital,” said COUR Pharmaceuticals CEO John Puisis.

 

Comments Off on Cour Pharma Expands at ISTP Blog, News

Read more

ISTP Ownership Changes

These recent sales highlight property types for which real estate investors have clamored during the COVID-19 pandemic: high-quality life sciences research buildings and office buildings with big, single tenants with good credit and long-term leases. The former has benefited from a rush of venture capital pouring into biotech and pharmaceutical research throughout the public health crisis, while the latter has drawn buyers looking for safe places to invest amid economic uncertainty

A venture of Hallandale Beach, Fla.-based TopMed Realty bought the 233,588 -square-foot office building at 4901 Searle Parkway. The building, which is almost fully leased to NorthShore University HealthSystem on a long-term deal, was purchased from a venture of Skokie-based American Landmark Properties

The sale comes a month after American Landmark sold the life sciences lab portion (8025 and 8045 Lamon Ave.), the majority of the leased 22.6-acre ISTP campus to Chicago-based investor Singerman Real Estate. The portfolio is comprised of a mix of highly technical wet lab and GMP space and is home to established global life sciences brands as well as prestigious university affiliated venture backed startups.

Noted Sam DiFrancesca and Lucas Borges of the JLL Capital Markets team…. “We were encouraged by the depth of capital with an interest in Greater Chicago and are excited to see such an established national life sciences investor as Singerman committing to the market,” “The level of lender interest in this portfolio is further testament to Chicago’s significant growth potential within the life sciences space.” Max Zwolan and Scott Brandwein of JLL also supported the transaction and will continue to handle the leasing for the buyers.
For the entire article, click here.

Comments Off on ISTP Ownership Changes Blog, News

Read more

NU Record Research Funding

Northwestern Research Funding- Record $893M.  Northwestern University’s research enterprise once again demonstrated strong performance, with annual sponsored funds reaching a new record high of $893.4 million for the fiscal year that closed Aug. 31. This represents an increase of 1% from last year’s total and continues a decade-long trend that has positioned Northwestern among the nation’s most prestigious research institutions. Since 2011, the University’s research funding has increased more than 74% as Northwestern approaches $1 billion in sponsored support, a feat achieved by only its top academic peers.

“The remarkable depth and breadth of Northwestern research continues to make a huge positive impact, transforming entire fields and strengthening society,” Milan Mrksich, vice president for research. said. “As we continue to go from strength to strength — including important investments in our entrepreneurial and innovation ecosystem to increase translation — we will enhance our already superb research enterprise to keep elevating Northwestern’s reputation as a premier destination for the best scholars, scientists and students in the world.”

“Our research portfolio now includes a higher percentage of larger, complex awards, reflecting the collaborative approach to research that Northwestern fosters,” said Shandra White, executive director of Sponsored Research. “Having diverse projects within Northwestern’s research landscape is vital, along with the robust infrastructure to support the complexity of those high-impact investigations.”

For more about NU, click here.

Comments Off on NU Record Research Funding Blog, News

Read more

Chicago Area Life Science Cluster

A life sciences cluster has also grown in recent years in and around Chicago, where three federal laboratories, several biopharma giants, and an emerging community of startups are buttressed by a strong base of academic research institutions—including Northwestern University, the University of Chicago, and the University of Illinois.

The bioscience industry’s economic footprint reaches into so many local communities across the country. From capital investments to research & development, this report shows the impact of the biosciences across the nation’s innovation ecosystem.

In Illinois, life sciences employers grew their employment base since 2016, increasing by 3.2 percent reaching nearly 88,000 direct jobs. Research also ranked in the top tier of all states in life sciences related academic R&D activities. Illinois research institutions spent nearly $1.6 billion in 2018 on R&D.

“The bioscience industry is critically important to Illinois and we are proud to work closely with partners like iBIO to help ensure the future of the industry and its role as an economic driver in the region,” said Pete Pellerito, BIO Senior Policy Adviser for Federal and State Economic Development and Technology Transfer Initiatives. To access the entire article, click here.

Comments Off on Chicago Area Life Science Cluster Blog

Read more